Messino Cancer Centers

What Messino Cancer Centers does

Messino Cancer Centers is a community-based oncology practice founded in 1990 by Dr. Michael Messino that provides comprehensive cancer and blood disorder treatment to adult patients across six clinic locations in Western North Carolina (Asheville with two sites, Brevard, Franklin, Marion, and Sylva). The practice operates an integrated care platform combining diagnostic imaging (on-site ACR-accredited CT and PET/CT), centralized pathology, advanced treatment modalities (chemotherapy, immunotherapy, BiTE therapy, radioligand therapy with Pluvicto/Lutathera/Xofigo, FDA-approved Optune wearable for glioblastoma), an in-house specialty pharmacy with FedEx home delivery, dignity-preserving supportive care (DigniCap scalp cooling), and ancillary services including care coordination, clinical trial access, financial counseling, and telehealth. Its 13 board-certified physicians and 12+ advanced practitioners cover oncology subspecialties including neuro-oncology, thoracic oncology, breast/gynecologic oncology, palliative medicine, and hematologic malignancies.

Since January 2020, Messino has been a partner practice of American Oncology Network (AON, Nasdaq: AONC), a physician-led alliance spanning 350+ providers across 21 states. The AON partnership provides Messino with in-house specialty pharmacy infrastructure, centralized pathology, integrated electronic medical records, clinical trial access through 150+ active studies including Sarah Cannon Research Institute strategic sites, care management teams, and administrative support. The practice generates revenue predominantly through professional services billed to insurance, Medicare, and Medicaid, with additional revenue streams from diagnostic imaging, specialty pharmacy dispensing, clinical trial participation, and advanced therapy administration. New patient acquisition occurs through physician referrals, community presence, and a centralized new-patient intake line operating at (833) 758-0023.

The business model is a hybrid professional services and specialty pharmacy model. Pricing is not publicly disclosed; billing is insurance-dependent with financial counseling to support patient assistance enrollment. The practice has 27 employees and serves a rural-to-suburban geographic footprint that academic medical centers cannot easily serve, with services emphasizing whole-person, community-based care over high-volume urban oncology delivery.

Name

Messino Cancer Centers

Legal name

Messino

Website

https://messinocancercenters.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Messino Cancer Centers is a community oncology practice founded in 1990 that treats adult cancer and blood disorder patients across six Western North Carolina clinics, offering advanced therapies, on-site imaging, and specialty pharmacy through its American Oncology Network partnership.

Ownership category

akta.pro rank

Product category

Community Oncology Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Community oncology services
• Cancer treatment centers
• Medical oncology care
• Hematology services
• Specialty pharmacy dispensing

Headquarters

HQ city

Asheville

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Oncology Services: Revenue generated from medical oncology consultations, chemotherapy administration, hematology services, radiation oncology support, and follow-up care across six clinic locations in Western North Carolina.
2. Diagnostic Imaging Services: Revenue from on-site CT and PET/CT imaging procedures performed and interpreted at the practice, serving both active patients and external referrals.
3. In-House Specialty Pharmacy: Revenue from dispensing oral oncolytic and immunotherapy medications through the practice's in-house specialty pharmacy, with 24/7 pharmacist support and home delivery.
4. Clinical Trials: Revenue from participation in clinical research studies, providing access to experimental therapies while generating research compensation through the AON network affiliation.
5. Radioligand Therapy: Revenue from administering FDA-approved radiopharmaceutical therapies (Pluvicto, Lutathera, Xofigo) for eligible cancer patients, requiring specialized facilities and staff.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Messino Cancer Centers is a privately-held community oncology practice in Western North Carolina providing outpatient cancer treatment, including medical oncology, hematology, neuro-oncology, diagnostic imaging (CT/PET), laboratory services, oral specialty pharmacy dispensing, and clinical trials. It serves adult oncology patients across multiple clinic locations and a satellite clinic, and operates as a partner practice of American Oncology Network (AON).

Product overview

Messino Cancer Centers is a community oncology practice providing comprehensive cancer and blood disorder treatment. The practice operates as a unified care platform combining diagnostic services (on-site imaging and pathology), treatment services (chemotherapy, immunotherapy, BiTE therapy, radioligand therapy, Optune device), pharmacy services (in-house specialty pharmacy with oral oncolytics), and support services (care coordination, clinical trials, financial support, telehealth, survivorship programs). The integrated model allows patients to receive diagnosis, treatment, medication management, and support services within the community oncology setting.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology
• Hematology
• Neuro-Oncology
• Diagnostic Imaging
• Laboratory Services
• Oral Specialty Pharmacy
• Clinical Trials
• Financial Counseling

Quantifiable outcome

• 300+ radioligand treatments delivered to nearly 70 patients across AON network including Messino Cancer Centers
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• American Oncology Network (AON)coreStrategic or Co-development Partner · 1 January 2020Messino Cancer Centers is a partner practice of American Oncology Network (AON), a physician-led alliance of community oncology practices. The partnership, established January 2020, provides Messino with access to in-house specialty pharmacy, centralized pathology, integrated electronic medical records, care management teams, financial assistance programs, clinical trial access, and administrative support services. AON supports practice growth, enabling physicians to focus on patient care. AON's network spans 350+ providers across 21 states.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• The US Oncology Network: McKesson-backed network of community oncology practices offering similar services to AON. Comparable partnership-style platform supporting independent oncology practices with research, technology, and operational infrastructure.
• OneOncology: National partnership platform for independent community oncology practices, offering practice management, technology, and clinical research support. Directly comparable as a network alternative to AON for community oncology practices like Messino.
• City of Hope: Major NCI-designated cancer center and academic system delivering specialty oncology care including advanced therapies (radioligand, cellular therapy). Comparable for advanced treatment modalities that Messino is now bringing into the community setting.
• American Oncology Network (AON): Public parent network (Nasdaq: AONC) and partner organization of Messino Cancer Centers. A physician-led alliance of community oncology practices providing pharmacy, pathology, clinical trials, and administrative services — directly comparable business model to Messino but at national scale across 21 states.

Regional players

• New England Cancer Specialists: Independent community oncology and hematology practice serving northern New England with infusion, imaging, clinical trials, and survivorship programs. Comparable community oncology model delivering integrated cancer care at a regional level.

Direct peers

• Tennessee Oncology: Independent community oncology practice serving Tennessee with medical oncology, hematology, radiation, imaging, and clinical trials. Closely comparable as a regional community oncology practice with similar service breadth and physician-led structure.
• Florida Cancer Specialists & Research Institute: One of the largest independent community oncology practices in the U.S., offering medical oncology, hematology, clinical trials, and in-house pharmacy across Florida. Highly comparable community-based, physician-led model with similar service breadth to Messino.
• Texas Oncology: Large community oncology practice affiliated with The US Oncology Network, delivering medical oncology, radiation, imaging, and clinical trials across Texas. Closely mirrors Messino's integrated community oncology model with multi-location footprint.
• Regional Cancer Care Associates (RCCA): Multi-location community oncology practice serving the Northeast U.S. with medical oncology, hematology, infusion, and clinical research. Comparable regional community oncology model delivering integrated cancer care.

Emerging players

• Sarah Cannon Research Institute: Clinical research arm providing Messino (via AON) access to 150+ oncology trials through strategic site partnerships. Comparable as a clinical trials partner and emerging model for community-based oncology research delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/MessinoCancerCenters
• LinkedInlinkedin.com/company/messino-cancer-centers

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Messino Cancer Centers